Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 May;14(5):e009573.
doi: 10.1161/CIRCEP.120.009573. Epub 2021 Apr 9.

Radiofrequency Versus Cryoballoon Catheter Ablation for Paroxysmal Atrial Fibrillation: Durability of Pulmonary Vein Isolation and Effect on Atrial Fibrillation Burden: The RACE-AF Randomized Controlled Trial

Samuel K Sørensen  1 , Arne Johannessen  1 , René Worck  1 , Morten L Hansen  1 , Jim Hansen  1
Affiliations
Randomized Controlled Trial

Radiofrequency Versus Cryoballoon Catheter Ablation for Paroxysmal Atrial Fibrillation: Durability of Pulmonary Vein Isolation and Effect on Atrial Fibrillation Burden: The RACE-AF Randomized Controlled Trial

Samuel K Sørensen et al. Circ Arrhythm Electrophysiol. 2021 May.

Abstract

[Figure: see text].

Trial registration: ClinicalTrials.gov NCT03805555.

Keywords: atrial fibrillation; catheter ablation; cryosurgery; electrocardiography, ambulatory; pulmonary vein; radiofrequency ablation; recurrence; second-look surgery.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Randomization and patient (pt) flow in the RACE-AF trial. (Radiofrequency versus Cryoballoon Catheter Ablation for Paroxysmal Atrial Fibrillation - Durability of Pulmonary Vein Isolation and Effect on Atrial Fibrillation Burden) *Before pulmonary vein isolation (PVI), the diagnosis of atrial fibrillation was rejected in 2 pts. One did not have symptomatic arrhythmia; the other had ectopic atrial tachycardia. †Protocol was breached as the ablation method was switched from cryoballoon catheter ablation (CRYO) to radiofrequency catheter ablation (RF) to isolate the remaining 3 pulmonary veins in spite of a persistent phrenic nerve palsy. ICM indicates implantable cardiac monitor.
Figure 2.
Figure 2.
Durability of pulmonary vein isolation after radiofrequency (RF) and cryoballoon (CRYO) ablation. Top, Columns illustrate the number of pulmonary veins in total (left columns), with acute isolation achieved at the index procedures (middle columns) and with durable isolation found at the reassessment procedures (right columns). Bottom, Columns illustrate the number of durably isolated pulmonary veins per patient. In patients with pulmonary vein reconnection, the number of durably isolated pulmonary veins was similar for both treatment groups (P=0.31). NS indicates nonsignificant.
Figure 3.
Figure 3.
Atrial fibrillation (AF) burden before and after pulmonary vein isolation (PVI). The line chart illustrates the individual patient’s AF burden before and after PVI (excluding a 3 mo blanking period). Radiofrequency catheter ablation (RF)-patients are shown in red and cryoballoon catheter ablation (CRYO)-patients are shown in blue. The box plots represent the 10th and 90th percentiles (whiskers), the 25th and 75th percentiles (boxes), and the medians (lines inside the boxes). AF burden indicates % of time in AF; and NS, nonsignificant.
Figure 4.
Figure 4.
Pulmonary vein isolation (PVI) status and atrial fibrillation (AF) recurrence. Pie charts illustrate the percentage of patients with AF recurrence according to PVI status. AF recurrence rate was significantly associated with the number of durably isolated pulmonary veins (P<0.01).
See this image and copyright information in PMC

References

    1. Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, et al. . 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14:e275–e444.. doi: 10.1016/j.hrthm.2017.05.012 - PMC - PubMed
    1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, et al. ; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42:373–498.. doi: 10.1093/eurheartj/ehaa612 - PubMed
    1. Andrade JG, Champagne J, Dubuc M, Deyell MW, Verma A, Macle L, Leong-Sit P, Novak P, Badra-Verdu M, Sapp J, et al. ; CIRCA-DOSE Study Investigators. Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial. Circulation. 2019;140:1779–1788.. doi: 10.1161/CIRCULATIONAHA.119.042622 - PubMed
    1. Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, Elvan A, Arentz T, Bestehorn K, Pocock SJ, et al. ; FIRE AND ICE Investigators. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374:2235–2245.. doi: 10.1056/NEJMoa1602014 - PubMed
    1. Ravi V, Poudyal A, Pulipati P, Larsen T, Krishnan K, Trohman RG, Sharma PS, Huang HD. A systematic review and meta-analysis comparing second-generation cryoballoon and contact force radiofrequency ablation for initial ablation of paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2020;31:2559–2571.. doi: 10.1111/jce.14676 - PubMed

Publication types

MeSH terms

Associated data